CTNNB1 and adenoma: This study does not assign a single specific signaling mechanism by which loss of PKD1 inhibits CRC, although it excludes inhibition of WNT/CTNNB1 as one possibility, based on elevation of this pathway in Pkd1-mutated murine adenomas or in human tumors bearing somatic PKD1 mutations.